Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Goldenberg

Showing results (111-120 of 296) with videos related to

Pageof 30
Sort By:
Cancer|February 4, 2010
Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancerFrançoise Kraeber-Bodéré, Pierre-Yves Salaun, Aurore Oudoux, et al.
Leukemia & Lymphoma|August 1, 2002
Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents: a new generation of therapeuticsMiriam Hursey, Dianne L Newton, Hans J Hansen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 3, 2012
Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumabXiaochuan Chen, Chien-Hsing Chang, Rhona Stein, et al.
Blood|November 21, 2007
Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of actionZhengxing Qu, David M Goldenberg, Thomas M Cardillo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 2, 2014
SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibodyMark Rijpkema, Wim J Oyen, Desiree Bos, et al.
Plos One|February 14, 2013
Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathologyDavid M Goldenberg, David V Gold, Meiyu Loo, et al.
Molecular Immunology|July 4, 2006
Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximabJosette Carnahan, Rhona Stein, Zhengxing Qu, et al.
Molecular Cancer Therapeutics|July 29, 2010
Ranpirnase (frog RNase) targeted with a humanized, internalizing, anti-Trop-2 antibody has potent cytotoxicity against diverse epithelial cancer cellsChien-Hsing Chang, Pankaj Gupta, Rosana Michel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2017
Synthetic Lethality Exploitation by an Anti-Trop-2-SN-38 Antibody-Drug Conjugate, IMMU-132, Plus PARP Inhibitors in <i>BRCA1/2</i>-wild-type Triple-Negative Breast CancerThomas M Cardillo, Robert M Sharkey, Diane L Rossi, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2004
Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograftRosalyn D Blumenthal, Lou Osorio, Marianne K Hayes, et al.
Pageof 30

Showing results (111-120 of 296) with videos related to

Sort By:
Pageof 30
Cancer|February 4, 2010
Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancerFrançoise Kraeber-Bodéré, Pierre-Yves Salaun, Aurore Oudoux, et al.
Leukemia & Lymphoma|August 1, 2002
Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents: a new generation of therapeuticsMiriam Hursey, Dianne L Newton, Hans J Hansen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 3, 2012
Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumabXiaochuan Chen, Chien-Hsing Chang, Rhona Stein, et al.
Blood|November 21, 2007
Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of actionZhengxing Qu, David M Goldenberg, Thomas M Cardillo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 2, 2014
SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibodyMark Rijpkema, Wim J Oyen, Desiree Bos, et al.
Plos One|February 14, 2013
Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathologyDavid M Goldenberg, David V Gold, Meiyu Loo, et al.
Molecular Immunology|July 4, 2006
Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximabJosette Carnahan, Rhona Stein, Zhengxing Qu, et al.
Molecular Cancer Therapeutics|July 29, 2010
Ranpirnase (frog RNase) targeted with a humanized, internalizing, anti-Trop-2 antibody has potent cytotoxicity against diverse epithelial cancer cellsChien-Hsing Chang, Pankaj Gupta, Rosana Michel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2017
Synthetic Lethality Exploitation by an Anti-Trop-2-SN-38 Antibody-Drug Conjugate, IMMU-132, Plus PARP Inhibitors in <i>BRCA1/2</i>-wild-type Triple-Negative Breast CancerThomas M Cardillo, Robert M Sharkey, Diane L Rossi, et al.
Cancer Immunology, Immunotherapy : CII|December 14, 2004
Carcinoembryonic antigen antibody inhibits lung metastasis and augments chemotherapy in a human colonic carcinoma xenograftRosalyn D Blumenthal, Lou Osorio, Marianne K Hayes, et al.
Pageof 30